Autolus Therapeutics Ltd reported $-71.62M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -71.62M 10.99M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Silence Therapeutics USD -26.24M 3.6M Sep/2025